Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Celanese (CE) EBT (2016 - 2026)

Celanese filings provide 17 years of EBT readings, the most recent being $13.0 million for Q4 2025.

  • On a quarterly basis, EBT rose 100.85% to $13.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.2 billion, a 19.94% decrease, with the full-year FY2025 number at -$1.2 billion, down 19.73% from a year prior.
  • EBT hit $13.0 million in Q4 2025 for Celanese, up from -$1.4 billion in the prior quarter.
  • In the past five years, EBT ranged from a high of $714.0 million in Q3 2023 to a low of -$1.5 billion in Q4 2024.
  • Median EBT over the past 5 years was $180.0 million (2024), compared with a mean of $107.1 million.
  • Biggest five-year swings in EBT: soared 348.98% in 2021 and later plummeted 1493.64% in 2024.
  • Celanese's EBT stood at $622.0 million in 2021, then tumbled by 112.86% to -$80.0 million in 2022, then soared by 237.5% to $110.0 million in 2023, then plummeted by 1493.64% to -$1.5 billion in 2024, then skyrocketed by 100.85% to $13.0 million in 2025.
  • The last three reported values for EBT were $13.0 million (Q4 2025), -$1.4 billion (Q3 2025), and $135.0 million (Q2 2025) per Business Quant data.